References

 

Healthcare Professional?

Access additional information here

References

  1. Pawlosky RJ et al. Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. J. Lipid Res. 2001; 42(8):1257–1265.
  2. Hussein N et al. Long-chain conversion of [13C]linoleic acid and a-linolenic acid inresponse to marked changes in their dietary intake in men. J. Lipid. Res. 2005; 46:269–280.
  3. Schuchardt JP et al. Significance of long-chain polyunsaturated fatty acids (PUFAs) forthe development and behaviour of children. Eur J Pediatr 2010; 169:149–164.
  4. Sinn N and Bryan J. Effect of Supplementation with Polyunsaturated Fatty Acids and Micronutrients on Learning and Behavior Problems Associated with Child ADHD. J. Dev. Behav. Pediatr. 2007; 28(2):82–91.
  5. Richardson AJ and Montgomery P. The Oxford-Durham Study: A Randomized, Controlled Trial of Dietary Supplementation With Fatty Acids in Children With Developmental Coordination Disorder. Pediatrics 2005; 115(5):1360–1366.
  6. Johnson M et al. Omega-3/Omega-6 Fatty Acids for Attention Deficit Hyperactivity Disorder: A Randomized Placebo-Controlled Trial in Children and Adolescents J. Atten. Disord. 2009; 12(5):394–401.
  7. Omega-3 fatty acids and depression: new data. Harv Ment Health Lett 2003; 19:7.
  8. Jacobson TA. Role of n–3 fatty acids in the treatment of hypertriglyceridemia and cardiovascular disease. Am. J. Clin. Nutr. 2008; 87(suppl):1981S–90S.
  9. Burr GO et al. New deficiency disease produced by the rigid exclusion of fat from the diet. J. Biol. Chem. 1929; 82:345–367.
  10. Linscheer WG and Vergroesen AJ. Lipids. In: Modern Nutrition in Health and Disease. Shils ME, Olson JA, Shike M, eds. Lea and Febiger, Philadelphia, 1994.
  11. Su KP et al. Omega-3 fatty acids in major depressive disorder. A preliminary doubleblind, placebo-controlled trial. Eur Neuropsychopharmacol. 2003; 13:267–71.
  12. McKenney JM and Sica D. Prescription omega-3 fatty acids for the treatment of hypertriglyceridemia. Am J Health Syst Pharm. 2007; 64(6):595–605.
  13. Morris MC et al. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 1993; 88:523–33.
  14. Mita T et al. Eicosapentaenoic acid reduces the progression of carotid intima-media thickness in patients with type 2 diabetes. Atherosclerosis. 2007; 191:162–7.
  15. Health Effects of Omega-3 Fatty Acids on Asthma. Agency for Healthcare Research and Quality. Evidence Report/Technology Assessment. Number 91.
  16. Fortin PR et al. Validation of a meta-analysis: the effects of fish oil in rheumatoid arthritis J Clin Epidemiol. 1995; 48:1379–90.
  17. Vanek C and Connor WE. Do n–3 fatty acids prevent osteoporosis? American Journal of Clinical Nutrition. 2007; 85: 647–648.
  18. Augustsson K et al. A prospective study of intake of fish and marine fatty acids and prostate cancer. Cancer Epidemiol Biomarkers Prev. 2003; 12:64–7.
  19. Boelsma E et al. Nutritional skin care: health effects of micronutrients and fatty acids. Am. J Clin. Nutr. 2001; 73:853–864.
  20. Effects of Omega-3 Fatty Acids on Lipids and Glycemic Control in Type II Diabetes and the Metabolic Syndrome and on Inflammatory Bowel Disease, Rheumatoid Arthritis, Renal Disease, Systemic Lupus Erythematosus, and Osteoporosis. Agency for Healthcare Research and Quality. Evidence Report/Technology Assessment. Number 89.
  21. Dietary Reference Intakes: Recommended Intakes for Individuals National Academy of Sciences. Institute of Medicine. Food and Nutrition Board, 2002.
  22. Simopoulos AP. Human requirement for N-3 polyunsaturated fatty acids. Poultry Science 2000; 79(7): 961–970.